logo dark logo light logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet
logo dark logo light logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet
mobile-logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet
 

Research & Development

Sponsored Research Agreements
  • Comprehensive R&D Platform
  • Diversified Cannabinoid Delivery Technologies
  • Research Collaborators
  • Sponsored Research Agreements
  • Intellectual Property Estate

FACILITIES


HEBREW UNIVERSITY

BEN GURION UNIVERSITY OF THE NEGEV ISRAEL

LYOTROPIC DELIVERY SYSTEMS

logo

6080 Greenwood Plaza Blvd., Unit B
Greenwood Village, CO 80111
Phone: +1.385.241.3376
E-mail: admin@anandascientific.com

Company

  • Key Personnel
  • FAQ
  • Testimonials
  • Investor Information
  • Press Releases

Latest News

  • Ananda Scientific and the University of Nebraska Medical Center announce FDA approval of the IND for a PTSD trial.… https://t.co/n5CK3XQTwF
    2 days ago
  • 10 million. This is the number of Americans estimated to have abused prescription pain medication within the last y… https://t.co/GjdyzBrmlM
    1 week ago
  • CEO Today has recognized Ananda Scientific for its groundbreaking innovation and research that can impact the lives… https://t.co/DvOGr4Ba5g
    2 weeks ago
Copyright © 2020 ANANDA Scientific, Inc. All Rights Reserved.